Foshan institution of pathogenic microorganism | China
This academic summary highlights advanced expertise in medical research design, Oncology statistical analysis, biochemical and molecular biology techniques, cell culture methodologies, and bioinformatics, with a strong focus on respiratory syncytial virus research. The work emphasizes the development and optimization of molecular and immunological assays to support vaccine evaluation and translational research. Robust reverse transcription quantitative polymerase chain reaction and antibody enzyme linked immunosorbent assay methods were established to assess viral load and immune responses, providing reliable alternatives to commercially available detection systems while improving laboratory efficiency and accessibility. Comprehensive research efforts also include critical analysis of global vaccine development strategies, encompassing diverse technical routes such as live attenuated vaccines, subunit vaccines, vector based platforms, and nucleic acid approaches. These contributions integrate experimental data with comparative evaluation frameworks, offering valuable insights into vaccine design, efficacy assessment, and methodological standardization. In addition, the preparation of detailed molecular biology operation guidelines strengthened laboratory practices and ensured reproducibility of experimental workflows. Training activities focused on molecular cloning, polymerase chain reaction based assays, and data validation principles, supporting the development of independent experimental competence and high quality data generation. Overall, this body of work demonstrates a strong integration of experimental innovation, methodological rigor, and knowledge dissemination, contributing meaningfully to vaccine research, laboratory capacity building, and the advancement of evidence based evaluation methods in virology and immunological studies.
Featured Publications
Deng, L., Cao, H., Li, G., Zhou, K., Fu, Z., Zhong, J., Wang, Z., & Yang, X. (2025). Progress on respiratory syncytial virus vaccine development and evaluation methods. Vaccines, 13(3), 304.